TEDDER THOMAS F has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VECTRON THERAPEUTICS AG, INNATE PHARMA SAS and POLYPHOR LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Sugars | |
#7 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Tedder Thomas F | 12 |
#2 | Hamaguchi Yasuhito | 4 |
#3 | Yazawa Norihito | 3 |
#4 | Gron Hanne | 3 |
#5 | Bouaziz Jean-David | 2 |
#6 | Yanaba Koichi | 2 |
#7 | Matsushita Takashi | 1 |
#8 | Iwata Yohei | 1 |
#9 | Liang Ying H | 1 |
#10 | Uchida Junji | 1 |
Publication | Filing date | Title |
---|---|---|
US2011104150A1 | Anti-CD19 antibodies and uses in B cell disorders | |
US2006134751A1 | Identification of novel MS4A gene family members expressed by hematopoietic cells |